Drug intelligence / Profile preview

apamin

Development stage
Unknown
Modality
Peptides
Administration
Injection, Intraperitoneal, Systemic
01

Overview

Apamin is an 18-amino acid globular peptide neurotoxin derived from bee venom (*Apis mellifera*). It is a highly selective blocker of small-conductance Ca2+-activated K+ (SK) channels, specifically the SK1, SK2, and SK3 subtypes, with the highest potency observed against SK2 (IC50 ~70 pM). Notably, apamin is the smallest known neurotoxin polypeptide and is unique for its ability to cross the blood-brain barrier. While it is not currently being developed as a therapeutic agent, apamin is widely utilized as a pharmacological tool in neuroscience research to study neuronal excitability and the role of SK channels in the afterhyperpolarization phase of action potentials. Furthermore, researchers are exploring modified versions of apamin as potential drug delivery vehicles to transport therapeutic agents across the blood-brain barrier for the treatment of spinal cord injuries and other central nervous system disorders.

Other names
apamine
02

Targets

KCNN1 (Small conductance calcium-activated potassium channel protein 1)SPHK2 (Sphingosine kinase 2)

Beyond the preview

Go deeper on apamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call